Seeing Is Believing
Currently out of the existing stock ratings of Bob Hopkins, 16 are a HOLD (25%), 46 are a BUY (71.88%), 2 are a SELL (3.13%).
Analyst Bob Hopkins, carries an average stock price target met ratio of 67.7% that have a potential upside of 17.52% achieved within 221 days. Previously, Bob Hopkins worked at BAML.
Bob Hopkins’s has documented 134 price targets and ratings displayed on 18 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on INSP, Inspire Medical Systems at 20-Nov-2024.
Analyst best performing recommendations are on XENT (INTERSECT ENT).
The best stock recommendation documented was for XENT (INTERSECT ENT) at 4/15/2020. The price target of $10 was fulfilled within 2 days with a profit of $0.79 (8.58%) receiving and performance score of 42.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$160
$29.18 (22.31%)
$127
28 days ago
(04-Mar-2025)
14/16 (87.5%)
$19.78 (14.11%)
487
Buy
$158
$27.18 (20.78%)
$149
2 months 5 days ago
(27-Jan-2025)
19/23 (82.61%)
$28.57 (22.07%)
465
Buy
$148
$17.18 (13.13%)
$146
2 months 9 days ago
(23-Jan-2025)
11/13 (84.62%)
$24.78 (20.11%)
403
Buy
$135
$4.18 (3.20%)
$115
2 months 9 days ago
(23-Jan-2025)
14/14 (100%)
$11.78 (9.56%)
298
Buy
$135
$4.18 (3.20%)
$130
3 months 12 days ago
(20-Dec-2024)
17/18 (94.44%)
$21.37 (18.81%)
545
Which stock is Bob Hopkins is most bullish on?
Which stock is Bob Hopkins is most reserved on?
What Year was the first public recommendation made by Bob Hopkins?